[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349070-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349070-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","emerging-liquid-biopsy-tools-to-analyse-cancer-biomarkers-electrochemical-sensors-and-extracellular-vesicle-analysis","Emerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis","","Better biomarker analysis technologies can improve cancer detection, characterization, and monitoring while enabling less invasive sampling from blood and other body fluids. This review focuses on advances in electrochemical sensors for extracellular vesicle (EV) analysis and explains limitations of common biomarker tests such as ELISAs. It also discusses how EVs protect cargos and may enable enrichment of multiple tumour-derived biomarkers, supporting lower-cost, high-sensitivity quantitation and improving clinical outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/emerging-liquid-biopsy-tools-to-analyse-cancer-biomarkers-electrochemical-sensors-and-extracellular-vesicle-analysis/349070/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/emerging-liquid-biopsy-tools-to-analyse-cancer-biomarkers-electrochemical-sensors-and-extracellular-vesicle-analysis/349070.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is liquid biopsy considered beneficial for cancer biomarker analysis?","Question",{"text":63,"@type":64},"Blood-based sampling can enable minimally invasive, rapid detection of biomarkers released from cancerous tissues throughout the body, improving acceptability and supporting earlier diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are the main limitations of widely used biomarker tests such as ELISAs?",{"text":68,"@type":64},"ELISAs are limited by cost, storage and shelf-life requirements, difficulty of use outside centralized facilities, and detection limits that struggle with low-abundance biomarkers.",{"name":70,"@type":61,"acceptedAnswer":71},"How do electrochemical sensor platforms help with biomarker detection at very low concentrations?",{"text":72,"@type":64},"They can provide high sensitivity and direct quantitation at low cost, and can be simpler to use away from testing facilities, though platforms may require more effort to adapt for new analytes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349070,1790505956,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Biochemical Society Transactions (2026) 54 195–210 [https://doi.org/10.1042/BST20253109](https://doi.org/10.1042/BST20253109)  \nReview Article  \nEmerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis  \n Anitha Devadoss1 ,  Michael R. Furness1 ,  Nathan J.W. Wu1 , Olga Oikonomidou2 , Ma¨ıwenn Kersaudy-Kerhoas1 and  Nick R. Leslie1  \n1 Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, U. K. ; 2 Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, U. K.  \nCorrespondence: Nick R. Leslie ([N.R.Leslie@hw.ac.uk](N.R.Leslie@hw.ac.uk))  \nReceived: 22 July 2025  \nRevised: 21 January 2026  \nAccepted: 23 January 2026  \nVersion of Record published:  \n18 February 2026  \nBetter biomarker analysis technologies can provide improvements in the detection, characterisation and monitoring of cancer and less invasive sampling of blood and other body fluids can improve acceptability and affordability. Here, we discuss these technologies with a specific focus on recent advances in electrochemical sensors, specifically for the analysis of extracellular vesicles (EVs) . Widely used biomarker tests with relatively high sensitivity (e.g. ELISAs) are limited by their cost, storage requirements and shelf-life, and ease of use away from centralised facilities. Moreover, their limits of detection (most commonly in the nanomolar to picomolar, with new technologies pushing into the femtomolar range) remain challenged by low abundance biomarkers. Here, we discuss how electrochemical sensor platforms, although often requiring more effort to adapt for new analytes, can provide high sensitivity and direct quantitation at low cost. These platforms are also often simpler to use away from testing facilities. Additionally, we explore how EVs, by protecting nucleic acid and protein cargos from degradation, may facilitate the collective enrichment from blood samples of multiple tumour-derived biomarkers. Continued progress in analysis technologies, alongside a deeper understanding of biomarker biology and clinical value, holds the potential to improve outcomes for the increasing numbers of individuals diagnosed with cancer.  \nIntroduction  \nDriving earlier cancer detection and reducing diagnosis times have clear benefits to successful treatment and patient outcomes. Therefore, developing sensitive diagnostic and monitoring systems for the rapid detection of cancer biomarkers has become a strategic priority of healthcare delivery systems. By delivering and mixing material from tissues throughout the body, blood provides a potential source of informative biomarkers released by cancer cells and tumour stromal cells (in addition to small numbers of these cells themselves) without requiring invasive tissue biopsies. Sampling blood has the advantage of capturing materials released from cancerous tissues regardless of their location within the body. However, while it does not reveal where biomarkers have entered the bloodstream, blood-based analysis provides a minimally invasive route for rapid detection of cancer biomarkers.  \nHuman blood contains several classes of biomarker which can provide insight into potential cancers, including circulating tumour cells (CTCs), extracellular vesicles (EVs), DNA, RNA, proteins and metabolites, each with technologies to analyse them. Several excellent reviews have focused on CTCs, circulating tumour DNA and technologies to analyse these biomarkers, which also address the limitations of utilising these biomarkers for successful cancer diagnosis [1–3] . Here, we highlight recent  \n© 2026 The Author(s) . This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution 195 License 4 .0 (CC BY) .  \nBiochemical Society Transa","cbCailWXEccF0O2m","https://ap.wps.com/l/cbCailWXEccF0O2m","pdf",1721482,16,"English","# Introduction\n## Biomarkers within blood\n# Electrochemical sensors and EV analysis\n## Clinical evaluation: sensitivity, specificity, and context","[{\"question\":\"Why is liquid biopsy considered beneficial for cancer biomarker analysis?\",\"answer\":\"Blood-based sampling can enable minimally invasive, rapid detection of biomarkers released from cancerous tissues throughout the body, improving acceptability and supporting earlier diagnosis.\"},{\"question\":\"What are the main limitations of widely used biomarker tests such as ELISAs?\",\"answer\":\"ELISAs are limited by cost, storage and shelf-life requirements, difficulty of use outside centralized facilities, and detection limits that struggle with low-abundance biomarkers.\"},{\"question\":\"How do electrochemical sensor platforms help with biomarker detection at very low concentrations?\",\"answer\":\"They can provide high sensitivity and direct quantitation at low cost, and can be simpler to use away from testing facilities, though platforms may require more effort to adapt for new analytes.\"}]","Emerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis | PDF",1790081492,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8a9fb9ab567c25e5e77b96f28fa654e.webp",983,1301,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f851fdbe6f1f9ccd51fa42e39b295c08.webp",982,1299,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c94474a6c8c41d3b47f8d5ddf8e3b44.webp",981,1298,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/889459f268c253f17658707df78ba76b.webp",980,1297]